Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders
ConclusionsCSF α-synuclein is associated with CSF tau levels and could predict neurodegeneration and clinical progression in non-demented elders. This finding indicates that CSF α-synuclein is a potentially useful early biomarker for AD.
Source: Translational Neurodegeneration - Category: Neurology Source Type: research
More News: Brain | China Health | Databases & Libraries | Dementia | Neurology | Study | Training | Universities & Medical Training